Your Search for 'OTC Pharmaceuticals - Italy - a snapshot (2011)' returned 14 results - Page 1 of 1

• Italy Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Feb 2012 , Pages: 82
  -containment efforts. Headline Expenditure Projections - Pharmaceuticals: EUR24.90bn (US$34.63bn) in 2011 to EUR23.52bn (US$31.52bn) in 2012; -5.5% in local currency terms (-9.0% in US dollar terms ...

• Pharmaceuticals - Global Outlook

  EURO€ 1,766.00USD$ 1,995.00GBP£ 1,177.00AUD$ 2,759.00JPY¥ 239,238.00SEK 15 694,00CHF 2'627.00CAD$ 2,559.00 Global Industry Analysts, Inc, Jan 2012 , Pages: 443
  for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ...

• Italy Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Dec 2011 , Pages: 77
  from jittery financial markets, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio Berlusconi. The austerity ...

• Italy Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 92
  Italy Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ...

• Italy Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 80
  Italy Pharmaceuticals and Healthcare Report Q1 2011 Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Italy Pharmaceuticals and Healthcare Report Q2 2009

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Apr 2009 , Pages: 68
  Italy Pharmaceuticals and Healthcare Report Q2 2009 Italy Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare ...

• Italy Pharmaceuticals and Healthcare Report Q4 2010

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Aug 2010 , Pages +: 75
  %. Furthermore, aiming to make annual savings of at least EUR600mn (US$768mn), the Italian agency for pharmaceuticals (AIFA) is to review the pharmaceutical expenditure of the various territorial regions in Italy ...

• Italy Pharmaceuticals and Healthcare Report Q1 2009

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Feb 2009 , Pages: 67
  two acquisitions by 2011. On the regulatory front, the Italian medicines agency (AIFA) has put forward plans to significantly expand its workforce. New agency director Guido Rasi – appointed following ...

• Spain Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Oct 2011 , Pages: 99
  Projections: Pharmaceuticals: EUR16.08bn (US$21.33bn) in 2010 to EUR15.57bn (US$22.26bn) in 2011; -3.2% in local currency terms and +4.4% in US dollar terms. Healthcare: EUR103.15bn (US$136.83bn) in 2010 to ...

• Spain Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jan 2011 , Pages: 93
  Spain Pharmaceuticals and Healthcare Report Q1 2011 The Spain Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Spain Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jan 2012 , Pages: 91
  opportunities. Headline Expenditure Projections: - Pharmaceuticals: EUR16.08bn (US$21.33bn) in 2010 to EUR15.57bn (US$22.26bn) in 2011; -3.2% in local currency terms and +4.4% in US dollar terms. - Healthcare ...

• Bausch & Lomb Incorporated Market Share Analysis

  EURO€ 769.00USD$ 1,000.00GBP£ 647.00AUD$ 978.00JPY¥ 98,733.00SEK 6 566,00CHF 943.00CAD$ 1,019.00 GlobalData, Sep 2011 , Pages: 145
  Incorporated’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, India, Japan, China, Spain, Germany, Italy, United Kingdom, France, Canada, United States ...

• India Pharmaceuticals and Healthcare Report Q1 2009

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Feb 2009 , Pages: 125
  continues to expand, both locally and abroad, although it has not all been plain sailing. In late 2008, Indian Zydus Cadila – a unit of Cadila Healthcare – purchased Italy-based Etna Biotech from Dutch ...

• Herbal Supplements and Remedies - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Mar 2013 , Pages: 552
  ): Percentage Share Breakdown by Country - US, Brazil, Argentina, China and Others (includes corresponding Graph/Chart) II-12 Table 4: Global Soybean Consumption by Leading Countries (2011): Percentage ...